The questions you actually arrive with about hormone therapy, answered plainly.

I cannot answer that from a web page, and I would be cautious about anyone who says they can. Candidacy is not settled by a symptom list, or by how strongly you recognise yourself in one.

It depends on your full history, what else is happening in your body right now, what you have already tried and how you responded, and what you are currently taking, including anything prescribed elsewhere. What actually determines it is an evaluation where those things are read together rather than one at a time.

Some women turn out to be good candidates. Some do not, and the honest answer is sometimes no. Either way, you should expect a reason you can follow rather than a verdict handed down.

No, and it does not mean the opposite either. A normal result means nothing was flagged against a reference range, which is a different statement from nothing is happening.

In perimenopause, hormone levels can move substantially from one week to the next, and sometimes from one day to the next. A single draw is a snapshot rather than the pattern. It tells us what was true on the morning you sat in the chair.

That is why I read labs alongside your symptoms, your timeline, and your history rather than on their own. The numbers are one input into the picture, not the whole of it, and where the two disagree, both still count as information.

I want to be straight with you about the limit of that: reading it this way does not guarantee we will find something. Sometimes the more useful result is a clearer account of what your body is telling you and a plan that takes it seriously.

Safety is not a single yes or no, and I would not be doing my job if I handed you one.

It depends on who is being treated. Your personal and family history, your age, how long it has been since your last period, what else you are managing, and what specifically is being considered all change the answer. Two women can ask the same question and be owed different responses.

It also depends on the state of the evidence, and this is an area where understanding has genuinely shifted over the past two decades as earlier research has been re-examined and read more carefully. Some things once said with great confidence are now stated with more nuance. Some questions remain unsettled. I am not going to resolve that on a web page, and I am not going to give you a risk number that sounds more certain than the evidence behind it.

The honest work is weighing your individual picture with a clinician who knows your history. A good version of that conversation covers what might make it reasonable in your case and, just as plainly, what would make it a poor idea for you.

The terms are used loosely, and that is most of the confusion.

Bioidentical describes hormones that are structurally identical to the ones your body produces. In practice that description covers two quite different situations. Some are regulated products that have gone through an approval process and are manufactured to a consistent, tested standard. Others are compounded preparations mixed by a pharmacy to an individual order, which sit in a different regulatory position with different oversight of consistency and testing.

Conventional is usually used to mean the approved, regulated products, and some of those are themselves structurally identical to your own hormones. So the two words are not opposites, and the way bioidentical is used in marketing does not by itself tell you how something is regulated.

I am not going to tell you here that one category is safer, more natural, or better than another. Which of these is appropriate for a particular woman is a clinical decision made with her, not a category preference decided in advance.

Some women notice change in some of those symptoms. Some notice change in one and not the others. Some notice little. The response is genuinely individual, and I cannot tell you in advance which of those you would be.

What I can tell you is how I think about it. Hormone therapy is one input, not the whole picture.

If you are the woman I usually meet, your sleep, your energy, and your focus have each been addressed separately already. Each attempt worked for about three weeks, and then everything settled back to where it started. Symptoms that have been treated one at a time rarely resolve because one more input is added in isolation.

That is why we read the whole pattern first, and why the order matters. Proper sequencing instead of piling on more tactics is not a slogan here. It is the reason we map before we change anything.

Yes. Women already on hormone therapy are welcome here, and you do not have to choose between what you are doing now and being evaluated properly.

I lead the initial clinical evaluation, and that includes a full review of everything you are taking, hormone therapy among it. I cannot connect the pattern without knowing what is already acting on it.

Where another clinician prescribes and manages your therapy, that relationship stays intact and I coordinate with them rather than around them. Any decision about that therapy remains an individual, clinician-supervised decision made with you and with the clinician responsible for it.

What we add is the wider read: how your therapy sits alongside your sleep, your energy, your labs, your history, and everything else that has been handled separately, so that you end up with one coordinated plan you can understand and sustain instead of several that never reference each other.

Timing does come into it, and you may have read as much. Your age, how long it has been since your last period, and where you sit in the transition are among the things a clinician weighs, which is exactly why they come up in an evaluation.

What I want to separate out is timing as a clinical consideration from timing as pressure. The first is real and worth discussing with someone who knows your history. The second is a sales technique, and you will not find it on this page.

There is no countdown here, no last chance, and no version of this where thinking it through carefully counts against you. If you want to know where you actually stand, that is precisely the kind of question an evaluation is for.

You book a consult, and we start with your history rather than with a product.

I lead the initial clinical evaluation myself. We go through your symptoms and when they began, what has been tried, what worked briefly and what did not, your labs if you have them, and everything you are currently taking.

Then I tell you what I see. That includes the parts I am not certain about, and anything I think needs a different kind of attention. If hormone therapy is reasonable to explore in your case, we discuss it in that context, with the clinician who would manage it involved where that applies. If it is not, I will say so plainly and tell you why.

Either way, you leave with the pattern explained and a clear sense of the next step. There is nothing to prepare beyond being ready to talk about your history.